Wird geladen...
Src family kinases differentially influence glioma growth and motility
Src‐family kinase (SFK) signaling impacts multiple tumor‐related properties, particularly in the context of the brain tumor glioblastoma. Consequently, the pan‐SFK inhibitor dasatinib has emerged as a therapeutic strategy, despite physiologic limitations to its effectiveness in the brain. We investi...
Gespeichert in:
| Veröffentlicht in: | Mol Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623998/ https://ncbi.nlm.nih.gov/pubmed/26105207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.06.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|